Search
Dulofibrate
go.drugbank.com/drugs/DB20032ExperimentalThe usage of the INN stem '-fibrate' in the name indicates that Dulofibrate is a clofibrate derivative, peroxisome proliferator activated receptor-a (PPAR-a) agonist. … Dulofibrate is a small molecule drug.
Pirifibrate
go.drugbank.com/drugs/DB20620ExperimentalThe usage of the INN stem '-fibrate' in the name indicates that Pirifibrate is a clofibrate derivative, peroxisome proliferator activated receptor-a (PPAR-a) agonist. … Pirifibrate is a small molecule drug.
Salafibrate
go.drugbank.com/drugs/DB20767ExperimentalThe usage of the INN stem '-fibrate' in the name indicates that Salafibrate is a clofibrate derivative, peroxisome proliferator activated receptor-a (PPAR-a) agonist. … Salafibrate is a small molecule drug.
Elarofiban anhydrous
go.drugbank.com/drugs/DB21212ExperimentalThe usage of the INN stem '-fiban' in the name indicates that Elarofiban anhydrous is a fibrinogen receptor antagonist (glycoprotein IIb/IIIa receptor antagonist). … Elarofiban anhydrous is a small molecule drug.
Lifibrate
go.drugbank.com/drugs/DB21399ExperimentalThe usage of the INN stem '-fibrate' in the name indicates that Lifibrate is a clofibrate derivative, peroxisome proliferator activated receptor-a (PPAR-a) agonist. … Lifibrate is a small molecule drug.
Hedera helix leaf extract
go.drugbank.com/drugs/DB13194InvestigationalHedera helix leaf extract allergenic extract is used in allergenic testing.
IL21120033
go.drugbank.com/drugs/DB32508ExperimentalIL21120033 is a first-in-class, small-molecule selective CXCR7 agonist.
Onvansertib
go.drugbank.com/drugs/DB15110InvestigationalOnvansertib is under investigation in clinical trial NCT03303339 (Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML).).
Iseganan
go.drugbank.com/drugs/DB16010InvestigationalIseganan is under investigation in clinical trial NCT00022373 (Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer).
Vixarelimab
go.drugbank.com/drugs/DB16350InvestigationalVixarelimab is under investigation in clinical trial NCT03816891 (A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Prurigo Nodularis).